Extended-spectrum ß-Lactamase-producing Enterobacteriaceae as a Common Cause of Urinary Tract Infections in Sri Lanka
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) are increasingly reported as pathogens in urinary tract infections (UTIs). However, in Sri Lanka, the clinical and molecular epidemiology of ESBL-PE implicated in UTIs has not been well described. Materials and Methods: We conducted prospective, laboratory-based surveillance from October to December 2013 at a tertiary care hospital in southern Sri Lanka and enrolled patients ≥1 year of age with clinically relevant UTIs due to ESBL-PE. Isolate identity, antimicrobial drug susceptibility, and ESBL production were determined. Presence of ß-lactamase genes, blaSHV, blaTEM, and blaCTX-M, was identified by polymerase chain reaction. Results: During the study period, Enterobacteriaceae were detected in 184 urine samples, with 74 (40.2%) being ESBL producers. Among 47 patients with ESBL-PE who had medical records available, 38 (80.9%) had clinically significant UTIs. Most UTIs (63.2%) were community acquired and 34.2% were in patients with diabetes. Among 36 cultured ESBL-PE isolates, significant susceptibility (>80%) was only retained to amikacin and the carbapenems. The group 1 blaCTX-M gene was present in 90.0% of Escherichia coli isolates and all Klebsiella pneumoniae and Enterobacter cloacae isolates. The blaSHV and blaTEM genes were more common in K. pneumoniae (75% and 50%) and E. cloacae (50% and 50%) isolates than in E. coli (10% and 20%) isolates, respectively. Conclusion: The majority of UTIs caused by ESBL-PE were acquired in the community and due to organisms carrying the group 1 CTX-M ß-lactamase. Further epidemiologic studies of infections due to ESBL-PE are urgently needed to better prevent and treat these infections in South Asia.
Abstract
Background: Extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) are increasingly reported as pathogens in urinary tract infections (UTIs). However, in Sri Lanka, the clinical and molecular epidemiology of ESBL-PE implicated in UTIs has not been well described. Materials and Methods: We conducted prospective, laboratory-based surveillance from October to December 2013 at a tertiary care hospital in southern Sri Lanka and enrolled patients ≥1 year of age with clinically relevant UTIs due to ESBL-PE. Isolate identity, antimicrobial drug susceptibility, and ESBL production were determined. Presence of ß-lactamase genes, blaSHV, blaTEM, and blaCTX-M, was identified by polymerase chain reaction. Results: During the study period, Enterobacteriaceae were detected in 184 urine samples, with 74 (40.2%) being ESBL producers. Among 47 patients with ESBL-PE who had medical records available, 38 (80.9%) had clinically significant UTIs. Most UTIs (63.2%) were community acquired and 34.2% were in patients with diabetes. Among 36 cultured ESBL-PE isolates, significant susceptibility (>80%) was only retained to amikacin and the carbapenems. The group 1 blaCTX-M gene was present in 90.0% of Escherichia coli isolates and all Klebsiella pneumoniae and Enterobacter cloacae isolates. The blaSHV and blaTEM genes were more common in K. pneumoniae (75% and 50%) and E. cloacae (50% and 50%) isolates than in E. coli (10% and 20%) isolates, respectively. Conclusion: The majority of UTIs caused by ESBL-PE were acquired in the community and due to organisms carrying the group 1 CTX-M ß-lactamase. Further epidemiologic studies of infections due to ESBL-PE are urgently needed to better prevent and treat these infections in South Asia.
참고문헌 (30)
- Livermore DM, "Fourteen years in resistance", Int J Antimicrob Agents, 39, pp.283~294 (2012)
- Wellington EM, "The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria", Lancet Infect Dis, 13, pp.155~165 (2013)
- Hammami S, "Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia", Microb Drug Resist, 19, pp.231~236 (2013)
- Lau SM, "Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection", J Microbiol Immunol Infect, 37, pp.185~191 (2004)
- Meier S, "Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy", Infection, 39, pp.333~340 (2011)
- ARSP Working Group, "The Sri Lanka College of Microbiology. A multi centre laboratory study of Gram negative bacterial blood stream infections in Sri Lanka", Ceylon Med J, 58, pp.56~61 (2013)
- Dissayanake D, "The distribution and characteristics of Extended-Spectrum β-Lactamase producing Escherichia coli and Klebsiella species among urinary isolates in a tertiary care hospital", Sri Lankan J Infect Dis, 2, pp.30~36 (2012)
- Patabendige C, "Antimicrobial resistance in resource-poor settings-- Sri Lankan experience", Regional Health Forum, 15, pp.18~26 (2011)
- "Device-associated module (UTI)"[URL]
- Horcajada JP, "Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance", Clin Microbiol Infect, 19, pp.962~968 (2013)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial disk susceptibility tests;approved standard", CLSI, ~ (2012)
- "Laboratory detection of extended-spectrum beta-lactamases (ESBLs)"[URL]
- "Modified hodge test for carbapenemase detection in Enterobacteriaceae"[URL]
- Barguigua A, "Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco", J Med Microbiol, 60, pp.1344~1352 (2011)
- American Thoracic Society, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia", Am J Respir Crit Care Med, 171, pp.388~416 (2005)
- Woerther PL, "Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M", Clin Microbiol Rev, 26, pp.744~758 (2013)
- Chander A, "Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal", BMC Res Notes, 6, pp.487~ (2013)
- Nandagopal B, "Frequency of extended spectrum β-lactamase producing urinary isolates of Gram-negative bacilli among patients seen in a multispecialty hospital in Vellore district, India", Indian J Med Microbiol, 33, pp.282~285 (2015)
- Bajpai T, "Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy", Indian J Pathol Microbiol, 57, pp.407~412 (2014)
- Mukherjee M, "Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. coli which were isolated from hospitalized patients in Kolkata, India", J Clin Diagn Res, 7, pp.449~453 (2013)
- Habeeb MA, "Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan", Pak J Med Sci, 29, pp.540~544 (2013)
- Calbo E, "Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases", J Antimicrob Chemother, 57, pp.780~783 (2006)
- Dortet L, "Sri Lanka, another country from the Indian subcontinent with NDM-1-producing Enterobacteriaceae", J Antimicrob Chemother, 68, pp.2172~2173 (2013)
- Papagiannitsis CC, "Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Enterobacter cloacae from a Czech patient previously hospitalized in Sri Lanka", Folia Microbiol (Praha), 58, pp.547~549 (2013)
- Hall JM, "Molecular mechanisms of β-lactam resistance in carbapenemase-producing Klebsiella pneumoniae from Sri Lanka", J Med Microbiol, 63, pp.1087~1092 (2014)
- Woodford N, "Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK", J Antimicrob Chemother, 54, pp.735~743 (2004)
- Smet A, "Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections", Microb Drug Resist, 16, pp.129~134 (2010)
- Chen LF, "Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States", Antimicrob Agents Chemother, 58, pp.1200~1202 (2014)
- Harris AD, "How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition", Am J Infect Control, 35, pp.97~101 (2007)
- Woerther PL, "Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger", Clin Infect Dis, 53, pp.677~685 (2011)